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Abstract: A wide variety of bacteria are found to be the tiny factories in the production of polyhydroxyalkanoate (PHA) biopolymer. PHA is the polyesters of 3-hydroxyalkanoic acids which occur in some bacteria when they are subjected to nutrient limitation and simultaneously fed with an excess amount of carbon. This unfavorable condition forces the bacteria to store carbon in the form of resorbable cellular inclusions called PHA. Biosynthesized PHA has the ability to replace the currently feasible harmful petroleum based plastics to bio-based plastics. PHA research is being focused mainly on two facts -bulk production of environment friendly low-cost PHA and functional group modification for multiple applications to mankind. Many companies are already producing PHA with highly tunable properties and are looking into economically feasible technologies for mass production of PHA. The core focus of PHA research includes a selection of potential PHA producers and low to zero cost carbon sources such as carbon containing wastages of household, farms and industries. This challenge of "trash to treasure" still remains to attained. Tunable properties of PHA have made them a more interesting biomaterial to blend with suitable biopolymers including bioactive compounds. Under precise physiological environment, PHA blends can deliver promising mechanical properties, acting as effective drug carriers and showing time bound degradation. Perhaps desirably tuned PHA may address many health issues including orthopedics -load bearing cartilage, artificial membranes for kidneys, heart and wound management. PHA has high immunotolerance, low toxicity and sustained biodegradability, which have attracted diverse scientists with many medical advancements such as bioabsorbable sutures and 3D structures. In the near future, it is expected to derive many smart auto controllable products from PHA such as microsphere, which could be used for a range of applications much more than Bio-harmonious PHAs are structurally simple macromolecules manufactured by several Grampositive and Gram-negative bacteria under imbalanced growth condition (Fig. 2) [1, 2] . During normal bacterial growth, the 3-ketothiolase is inhibited by free CoA, thereby leaving the Krebs cycle. Whereas, during stress conditions (depletion of nutrients such as nitrogen, oxygen, phosphate and/or iron), a higher concentration of acetyl-CoA is formed inside the cell, instead of CoA. Biosynthesis of poly-3-hydroxybutrate [P(3HB)] starts by the condensation of two acetyl-CoA molecules. The purified PHA is used in many biomedical applications due to its multifaceted properties like nontoxic, higher surface energy, interface adherence, porosity, superior flexibility, piezoelectric, biocompatibility and total biodegradability [3] [4] [5] [6] [7] . PHA decomposes into non-invasive compounds which are eliminated from the body by natural metabolic processes [8] . In 1888, Beijerinck observed granules in the bacterial cell, whereas Lemoigne isolated [P(3HB)] from the Bacillus megaterium in 1927. And for the first time, Macrae and Wilkinson in 1958 concluded that [P(3HB)] is a reserve material in bacteria [9] . In 1968 Griebel proposed the composition of [P(3HB)] granules of B. megaterium which comprised of 97.7% polyester, 1.87% proteins and 0.46% phospholipids [10] . Currently [P(3HB)] has attracted much attention in the medical field, and in future could expect PHA and its copolymers to be used in many useful medical applications [11] . PHA polymers are formed from various saturated and unsaturated hydroxyalkanoic acids and thus the term "polyhydroxyalkanoate" has diverse structures which are accompanied by interesting thermal and mechanical properties. PHA can be modified by blending with various polymers and nanocomposites to meet the demanding applications. Remarkably, PHA is a non-carcinogenic [12] , nontoxic [13] , nonpyrogenic, nonirritant, nonhemolytic, not genotoxic [14] and a completely degradable biopolymer (Fig. 3 ) via natural metabolic pathways in the body [15] [16] [17] . polypropylene (Prolene®) and polydioxanone (PDSII®) [18] . In recent years, PHA is also found to be employed in biomedical applications especially in tissue engineering [5, 19, 20] , drug delivery [21, 22] , and in wound management [23, 24] . Much remains to be achieved, in particular, construct synthesis pathway to obtain fine PHA granules in a short period, quality non-toxic PHA extraction with minimum cost and functional group modification for integrating other new technologies into the field. Looking into the importance of PHA, this review focuses on the improved properties of PHA blends, tissue engineering applications, challenges and future prospects.
Types of PHA
PHAs are optically active organic molecules that consist of various side chains and fatty acids with a hydroxyl group at 3 rd , 4 th or 5 th position (Fig. 4) [25, 26] . There are three different types of bacterial PHA based on the number of carbon atoms in the monomeric units (Table 1) . PHA synthase (PhaC), a polymerizing enzyme influences on the type of PHA synthesized by a microorganism [27, 28] . Also the structure, physical and chemical properties of PHA vary depending on the type of carbon source and organisms used in fermentation process [29] . A short-chain-length, SCL-PHA consists of 3-5 carbon atoms; medium-chain-length, MCL-PHA consists of 6-14 carbon atoms; and a long-chain-length, LCL-PHA obtained from long chain fatty acids containing more than 14 carbon atoms [30, 31] . Nearly 150 different monomeric units of PHA are recognized in homo or copolymers and their properties demonstrate a range of applications [2, 32] . Microbes utilize different carbon sources and substrates to produce the following poly-3-hydroxybutyrate (PHB) or PHA homopolymers, copolymers; poly-3-hydroxybutyrate-co-3-hydroxyvalerate (PHBV) or poly-3-hydroxybutyrate-co-3-hydroxyhexanoates (PHBHHx) or Poly-3-hydroxyoctanoate (PHO) [33] [34] [35] [36] [37] [38] . 
Biosynthesis of PHA
Biopolymers zenith PHA is naturally produced by >300 microorganisms including Ralstonia eutropha (Cupriavidus necator), Aeromonas hydrophila, Pseudomonas putida, cyanobacteria and recombinant Escherichia coli [11, [44] [45] [46] . In a scenario of nutrient famine, citrate synthase enzyme is inhibited and a high concentration of acetyl CoA is formed inside the cell, instead of regular CoA. Hence, the entry of acetyl CoA into Krebs cycle is restricted and the synthesis of PHA begins. So far, eight pathways of PHA biosynthesis have been found out; among which three main pathways were explained in figure 5 . [47, 48] . Among the microbes, C. necator (involves 3 main enzymes β-ketothiolase, NADPH-dependent acetoacetyl-CoA reductase and PHA synthase) was investigated to the maximum extent. The selected strains of C. necator are widely used for the commercial production of poly 3-hydroxybutyrate [P(3HB)], poly-(R)-3-hydroxybutyrate-co-4-hydroxybutyrate) [P(3HB-co-4HB)] and poly-(R)-3-hydroxybutyrate-co-(R)-3-hydroxyvalerate) (PHBV). The functional group -R has the flair to shift to different copolymers of PHA depending on the type of carbon source provided to bacterial host at the growth phase. Even though finding hastened, PHA research and its production are still at the academic level. Thus, much effort is needed to channel up, such as the selection of potential host and tailoring pathway, while maintaining the same outstanding properties. Large scale production could address the current environmental problems , toxic gases associated with synthetic plastic and shrinking petroleum reserves. To achieve a successful bulk production of PHA it is necessary to harmonize the basics of PHA. Bacterial molecular modeling is needed for a maximum accumulation of PHA and by proper optimization of process conditions the deposition of PHA at an early log phase could be controlled. This maximizes mitosis phase to get a higher number of cells which ultimately results in a higher yield of PHA. More importantly, the above-mentioned simple step of governing bacterial log phase can increase the production of PHA. Besides, it becomes necessary to focus on extracting the maximum amount of PHA in a less time more economically and without any toxic residuals. CoA : coenzyme A, ACP: acyl carrier protein, medium chain lenghth (MCL) small chain length (SCL)
Properties of PHA
A homopolymer, SCL-PHA exhibits stiffness and brittleness. Many PHA monomers are being reported homopolymer, copolymer and heteropolymers based on their chemical composition (side chain length). PHA monomers has many essential and critical properties including its biodegradability (Table 2) , flexibility, thermal and mechanical properties [49] which are similar to petroleum-based plastics such as isotactic polypropylene. Bacterial [P(3HB)] has many features such as semi crystallinity 1.26 g/cm -3 , amorphous 1.18 g/cm -3 , average molecular weight ranges from 1 x 10 4 to 3 x 10 6 g/mol with the polydispersity of about 2, glass transition temperature of around 5 °C, melting temperature of about 180 °C, Young's modulus of 3.5 GPa and a tensile strength of 43 MPa as well as elongation at break of 10 % [2, [50] [51] [52] [53] . MCL-PHA possesses low glass transition and low melting temperature which closely resembles elastomers or rubbers. Low molecular weight PHA and low comonomer content are suitable for injection molding. Medium molecular weight PHA with 10% comonomer is found to be suitable for thermoforming, lamination and casting films. Whereas, high molecular weight PHA with 15% comonomer is softer, elastic and adhesive, such as gloves [54] . These diversities made PHA to be applied into various fields, including biomedical [55] , packaging [56] , fibers [57] , drug release [58] . Table 2 . A summary of in vitro and in vivo studies of the biodegradability of PHA
Biodegradability and biocompatibility
PHA degradation perhaps befalls through physical, chemical or biological processes. Biodegradation is mediated via agents such as lipases, esterases and PHB depolymerase enzymes [66, 67] which hydrolyze PHB into building blocks (hydroxyacids -oligomers, monomers). In vivo the time duration for the biodegradation and resorption of PHA varies with size and processing, but is generally in between 12 and 18 months [18] without producing any toxic products [16, 68] . An implant of [P(4HB)] in the body can decompose into 4HB and then excreted from the body in the form of carbon dioxide and water. 4HB is the typical constituent of mammalian body normally found to be within muscle, fat, heart, brain, liver, lung, and kidneys [69] .
Fundamentally, the rate of biodegradation of PHA depends upon the environmental conditions such as temperature, moisture, pH, species and nutrient supplies, along with physical shape,
PHA
In vitro\In vivo
Intramuscular implantation of the microsphere to the Wistar rats for 3 months -prolong and continuous drug delivery [59] [P(3HB)],PHBV [P(3HB-4HB)] blends Implant for osteomyelitis therapy, the rate of antibiotic dissolution was substantially higher than that of polymer degradation. Antibiotic release from coated rods was sustained for 2 weeks at a constant rate [60] PHB/atactic Repair of a bowel defect in Wistar rats. 26 weeks postimplantation, material remnant was found in only one of the four animals.
[61]
Low crystallinity and rough surface degrades faster in activated sludge. After 18 days, 40% of [P(HB-co-12%-HHx)] and 20% of PHB were degraded, while Ecoflex only lost 5% of its weight. [P(HB-co-12%-HHx)] was degraded faster compared with PHB, [P(HB-co-5%-HHx)] and [P(HBco-20%-HHx)]
[62]
PHBHHx Ultraviolet (UV) radiation to achieve controlled degradation for PHBHHx. After 15 weeks of degradation in the simulated body fluid, films prepared from 8 and 16 h UVtreated PHBHHx powders maintained 92% and 87% of their original weights [59, 63, 64] [65]
7 of 37 crystallinity, additives, porosity, hydrophobic/hydrophilic nature, surface area, molecular weight and chemical composition [70] [71] [72] [73] . For example, Wistar rats were implanted subcutaneously with different Mw and thickness of PHB films [74] . Samples were isolated and the film weight, crystallinity degree and Mw of PHB were examined at specific times (0.5, 1, 2, 3 and 6 months). The outcomes obtained through the above studies indicate that the biodegradation depends on the Mw and thickness of the employed PHB films. Embodiment of PHB film with the thickness of 50 mkm and a Mw of 1000 kDa has shown the subsequent biodegradation of PHB film; 2% residual at the initial time i.e. 0.5 month, 6% at 2 months, 72% at 2.5 months and 100% in 3 months [74] . Chronology of biodegradation took place based on the following: the implanted PHB film was preliminarily covered with a fibrous capsule which then slowly lost its film weight, subsequently increased its crystallinity and decreased its Mw, which all led to the formation of macro cracks on PHB film. Finally, in the third phase accelerated fragmentation was observed until it vanished and localized [74, 75] . In an in vitro study, Thomas Freier and co-workers evaluated the Mw of pure PHB film (10x5 mm, about 5 mg) in sorensen buffer (0.1 m, with pH 7.4 at 37 0 C), where it reduced by one-half after a year [61] . Similar studies of in vitro and in vivo degradation of PHA are documented in table 2. Biodegradation is considered one of the unique properties of PHA biomaterial for various applications, besides biocompatibility. Upon tailoring the polymeric degradable composites and their ratio, the resulting candidate might be biocompetent which performs a time bound sustain drug release and degrades into a viable biologic system. It is presumed that the modified PHA biomaterial can release in a sustained manner the target amount and type of drug at different time intervals.
A biocompatible material for biomedical use is ought to be neither cytotoxic nor systemically invasive. Many studies suggest PHA as an elite biomaterial which has shown friendly biological environment at grafted site. PHA migrates with respect to tissue response. For example, Kohane et al. [76] demonstrated that a scaffold is biocompatible for subcutaneous tissue, perhaps not supportive for nerve tissue or peritoneum [76] .
Odermatt EK [14] reported an intramuscular implant fabricated with [P(4HB)] which showed excellent biocompatibility for its cytotoxicity, irritation, sensitization, systemic toxicity, pyrogenicity, genotoxicity, subchronic and chronic toxicity. Absorption was found to be significantly complete in about 64 weeks [14] . Minimal tissue reactivity and chronic inflammation were noted which were similar to silk or catgut implants [77] . The preliminary inflammation with PHA is perhaps in response to trauma (injection, surgery and implantation) which may vanish with time [78] . Few polymers have been suspected to elicit cancer, for example, silicone (polysiloxanes) [79] . Therefore, nontoxic, biocompatible PHA is widely gaining interest in developing many medical devices for the applications in orthopedic, cardiovascular, nerve guides, regenerative medicine, tissue engineering, adhesion barriers and wound management [5, 55, 80] . PHA modifications in terms of surface properties, external geometry, mechanical properties, porosity, various blends and their ratios could produce bio-smart materials; which may perhaps perform many duties by auto switchable surface with various tissues in human body. 
PHA blending
Although PHA is well known for its biocompatible flagship, on the other hand, PHA is also known to its demerits like fragility, low flexibility, limited functionalities and high production cost which hinder the leeway of this superlative biomaterial. A number of reports suggested that the disadvantages of parental PHA can be suppressed by tailoring their properties, formulation and processing conditions. Blend control polymer exploitation with successive productivity such as water permeability, sorption and diffusion regulated by modifying the properties of PHA [100] . Naturally, most of the polymers do not hold choice of functional groups, and thus blends, surface coatings, chemical modifications (addition or blocked) and treating conditions are fairly important for targeting to multiple applications. Intermingling is an easy and effective conduit, where many degradable polymers, growth factors, drugs, genes, carbons (e.g. graphene) and antibacterial agents are directly mix and process through electrospun, casting and spin coating to obtain bio-smart scaffold with multiple application potential. [101] .
Principally, PHA blends with other biodegradable polymers could reduce the cost of end product compare to the costly polymers [(P(4HB)] alone. While maintain the outstanding properties and design of final product. The desirable polymeric blends and plasticizers may significantly augment the performance through higher flexibility and elongation at break. [102] [103] [104] [105] [106] [107] . Qu et. al. [75] demonstrated an improved biodegradation rate of [P(3HB-co-3HHx)] and PEG blend. In another example, [P(3HB)]/poly(ɛ-caprolactone) (PCL) blends or poly(3-hydroxybutyric acid-co-4-hydroxybutyric acid) [(P(3HB-co-4HB)] -scaffolds has the potential in peripheral nerve repair strategies. [P(3HB)] brittleness and poor mechanical properties will not be suitable for nerve guidance conduits (NGC). To meet the requirements of NGC single lumen conduits were construct from [P(3HB)]/PCL blends and [P(3HB-co-4HB)]. An artificial guide is essential for large gap nerve regeneration, which is a slow progressing and sensitive process. NGCs with [P(3HB)] fibers are expected internal guidance on cellular scale that accelerates long gap regeneration. The conduit of [P(3HB)]/PCL blend exhibited adequate permeability, excellent bending property and mechanical strength. The adequate permeability provides nutrient and oxygen for cell survival inside the closed porous tubes in vitro. In this study, [P(3HB)]/PCL conduits maintained mechanical strength in phosphate buffered saline even after 16 weeks as compared to [P(3HB-co-4HB)]. Therefore P(3HB)/PCL has the potential in long gap peripheral nerve repair than [P(3HB-co-4HB)] that degraded faster and could be suitable for short term repair. [108] . Amenable trend of PHA captivated interest of polymer scientists around the world, and thus have widely investigated the various types of PHA-polymer blends such as PHB/PHBHHx [109] , oligo (R,S)-3HB-diol [110] , natural raw materials such as cellulose acetate butyrate [111] , starch acetate [112] , lignin [113] and synthetic biodegradable polymers i.e. PLA and PLLA [114] . As a result, many PHA based commercial products like Biomer, Minerv-PHA, Biogreen, Mirel, Goodfellow, Tepha are in the current medical trails and applications. Here, we will focus on the modification of PHA through blending of PHA with natural, synthetic materials and nanomaterials. (Fig 6) .
Blending with natural raw materials

Carbohydrate based blends
Long chain carbohydrates hold great promise as natural blending polymers due to their inherent biodegradability, low price and enormous availability. Therefore have been explored comprehensively in the blending of PHA especially PHB. In PHB blending one of the most studied carbohydrates is starch. It has been shown that the blending of PHB with starch improved the compatibility of PHB [115] . The films made of PHB:starch blends showed a single glass transition temperature (Tg) for all the proportions of PHB and starch mixtures [115] . Furthermore, the PHB:starch blends at a ratio of 7:3 (w/w) showed a marked increase in the tensile strength as compared to PHB. As starch is cheap, the blending of starch with the highest possible percentage might significantly decrease the cost of PHB and PHB derivatives without compromising on their physical properties. Starch acetate was also used for blending purpose which showed that the PHB:starch acetate blends were immiscible and the melting temperature (Tm) of PHB altered with the changes in the concentration of starch acetate in the blends, whereas the Tg of PHB in the blends were unchanged and remained constant at 9 °C [112] .
The presence of starch acetate in the PHB:starch acetate blends largely affected the temperature and enthalpy of crystallization of the blends. While the use of starch or starch acetate improved some of the mechanical properties and showed potential to reduce the production cost, however, these PHA blends were incapable of forming intact films which could be due to the lack of compatibility between PHA matrix and starch/starch acetate molecule. Use of grafted copolymer of starch and glycidyl methacrylate in PHBV blends significantly enhanced the tensile and flexural strengths of the blends as compared to PHBV and starch blends [116] . Moreover, an enhanced adhesion between starch-glycidyl methacrylate and PHBV matrix and fracture toughness in these blends were observed which indicate an improved compatibility of the blending components [116] . In a recent study, polyvinyl acetate-modified corn starch was also reported to improve the compatibility and flexibility of PHA:starch blends [117] . Besides starch, the derivatives of cellulose have been used widely as blending components with PHA largely because of their compatibility with PHA and their aptitude to augment the degradation of PHA. Studies showed an enhanced compatibility of PHB blends with different cellulose derivatives such as ethyl cellulose and cellulose acetate butyrate that significantly improved the physical and mechanical properties of the blends [111, 118] .
Lignin based blends
Lignin is considered to be a potent candidate for blending with PHA due to its amorphous nature and due to its free functional groups such as aliphatic and aromatic hydroxyl groups as well as carboxylic acid groups on the phenylpropane repeat units. Organosolv lignin and its butyrate derivatives showed better miscibility with PHB and also drastically retarded the crystal formation of PHB and thereby reduced the brittleness of PHB [119] . The blending of PHB with lignin fine powder reduces the crystallization half-time which drives the blend towards a favorable isothermal crystallization as compared to pure PHB [113] . Blending of soda lignin with PHB improves the thermal stability of PHB and the interaction between the carbonyl groups of PHB and the reactive functional groups of lignin was favored at a maximum concentration of soda lignin (40 wt%) [120] . The anti-degradation capacity of lignin was then examined by burying the PHB/lignin blends in garden soil [121] . In this study, lignin was suggested to reduce the rate of degradation of PHB in PHB/lignin blends. Lignin was found to form strong hydrogen bonds with PHB in the buried samples which might reduce the rate of breakdown of PHB and subsequently prevented the rapid degradation of PHB/lignin blends [121] . It was also demonstrated that lignin inhibited the colonization of microorganisms around PHB/lignin blends, thereby prevented the microbial degradation of the blends.
PHA co-polymers based blends
Physical and mechanical properties of PHAs markedly differ depending on their monomer composition and structure. Copolymerization of PHB, with monomers such as 3HD, 3HDD, 3HHx and 3HO, which results in the production of superior quality copolymers with improved thermal, mechanical, physicochemical and biological properties [122] . The [P(3HB)/4HB] copolymer exhibits a broad array of morphologies such as high crystalline to elastomeric based on the concentration of 4HB. Blending of different types of PHA together can radically improve the properties of PHA which in turn facilitates its applications. Chen et al. [109] showed that the growth of L929 cells was poor on PHB films, whereas their growth significantly improved on the films of PHB/PHBHHx blends. This difference in cell growth was explained by the high and rapid degree of crystallization which leaves pores and protuberances on the surface of PHB films. Whereas, the presence of PHBHHx in PHB/PHBHHx blend markedly reduces both the degree and rate of crystallization, hence the resulting blended films show quite regular and smooth surface which might have facilitated the attachment and growth of cells on the biofilms [123] . These findings indicate that the blending is also useful in enhancing the bioactive nature of the blended materials.
The copolymer, PHB-co-HV (poly-3-hydroxybutyrate-co-3-hydroxyvalerate), achieved an increased crystallization temperature (Tc) in comparison with PHB [124] . Recently, a nucleating agent, ULTRATALC 609 was examined for its efficiency in increasing the Tc and reducing the time for crystallization necessary for injection moulding. ULTRATALC 609 was found to enhance the decomposition temperature (Tdec) to some extent and showed a negligible effect on the Tm of all polymers. Both PHB and PHB-co-HV with 5 wt% of ULTRATALC 609 exerted higher Tc than polymers without ULTRATALC 609. A careful comparison of Tc, Tm and Tdec suggested that the PHB-co-HV copolymer with 20 mol% of HV would be the most excellent choice for injection moulding, with a high Tdec [124] . The immiscible binary blends such as [P(3HB)]/poly(propiolactone), [P(3HB)]/poly(ethylene adipate) and [P(3HB)]/poly(3-hydroxybutyric acid-co-hydroxyvaleric acid) degrade faster than their pure components and hastening in their degradation is attributable to the phase-separated structure [125] Fig.6 PHA modification through natural and synthetic raw materials.
Blending with synthetic biodegradable polymers
3.2.1. Poly-lactic acid (PLA) based blends PLA is a synthetic biodegradable polymer of lactic acid which can also be produced from glucose, maltose, sucrose and lactose by fermentation. PLA has been extensively used in biocompatible medical devices. Blending of PLA with other biodegradable polymers was shown effective in improving the compatibility of the polymers. The PLA/PHBV blend formed immiscible polymers where two types of morphologies were observed -nodular (when one component is less than 30 wt% of the other) and co-continuous (when both polymers are present in approximately equal ratio) [126] . PHBV polymer showed very low thermal stability; however, the PLA in the PLA/PHBV blend significantly improved the thermal stability of the blend. The PLA/PHBV blend was less brittle compared to individual polymers and the blend evidently showed a considerable ductile plastic deformation [126] . A blend consists of PLA and 10% PHA significantly improved the toughness and elongation at break by increasing the amorphous nature of PLA-PHA blends and by slowing down the crystallization kinetics of finely dispersed PHA particles [127] . In another study, PLA was blended with MCL-PHA and epoxy group modified PHA (ePHA). The resultant blends PLA/MCLePHA or PLA/ePHA were found to be immiscible in the amorphous state; however, the impact toughness of PLA was greatly enhanced as compared to PLA alone. The PLA/ePHA showed improved morphology, better physical properties and compatibility than PLA/MCL-PHA [128] .
Besides, Zhang et al. [129] exhibited that the PHA/PLA blends which were prepared by solvent casting method were less miscible than those prepared by melting at high temperatures. The Mw of PHA also greatly influences the miscibility of PHA with PLA. It was shown that PLA and low Mw atactic PHB (aPHB) (Mw 9400) are quite miscible in the melt with the highest presence of aPHB (50 wt%), whereas the blend of PLA and high Mw aPHB (Mw, 140,000) showed two Tg in the melt suggesting the immiscibility of the polymers [130] . The PHB/PLA blend shifted crystallization temperature of PLA towards a lower temperature with an increased concentration of PHB and resulted in the components of the blend to be completely immiscible with decreasing crystallization temperature. PHBHHx/PLA blends also shifted the crystallization temperature of PLA towards a higher temperature with increasing concentration of PHBHHx [114] . However, PHBHHx/PLA blends with mounting crystallization temperature were found to be slightly compatible with PHB/PLA [114] . The formed solid stereocomplex polylactide (sc-PLA) would be embedded in the poly(3-hydroxybutyrate-co-4-hydroxybutyrate) [P(3HB-co-4HB)] once the temperature of sc-PLA crystallinity reached a critical gel point (Fig. 7) . This simple melt blend of [P(34HB)] and sc-PLA exhibited superior mechanical and rheological properties [131] . 
Polycaprolactone (PCL) based blends
PCL is an aliphatic polyester, which is semicrystalline in nature and holds a high mechanical strength and ductility. Consequently, PCL has comprehensively been studied as a biomaterial in various biomedical applications. The blend of PHBHHx and PCL was used as a substrate in the engineering of musculoskeletal tissue [132] . Although PHBHHx has several advantages such as soft, flexible, low tensile strength, low Young's modulus, low degree of crystallinity and produce nontoxic degradation products, these polymers demonstrate insufficient mechanical strength and toughness for applications in tissue engineering [132, 133] . However, the inclusion of PCL in PHBHHx/PCL blend is suggested to enhance the toughness of PHBHHx with enough elasticity and the properties of this improved blend could be compared with the properties of a human bone [132, 133] . PHBHHx polymer can support the adhesion and proliferation of human fetal mesenchymal stem cells which suggests the potential of PHBHHx as a bone scaffold material [132] . Hollow fibers prepared from PHBV and PCL solutions in chloroform demonstrated a low degree of surface and bulk porosity depending on the ratio of the compositions present in the blend [134] . The PHBV/PCL blends displayed an increasing ductility with an increase in the concentration of PCL in the blends [134] . The addition of PCL in PHBV/PCL improved the biological properties of the blends which support the adhesion, viability, proliferation and migration of rat cerebral endothelial cells better than a pure PHBV polymer [135] .
Plasticizers based blends
Blending of PHA with plasticizers may offer improved processability of the blends by lowering the brittleness and processing temperature of PHA-based plastics ( Table 4 ). Plasticizers that are in use for blending of PHA ideally have a natural origin, low cost materials and readily available on the market. A low concentration of polyethylene glycol (PEG) (2-5%) was found to be well miscible and highly compatible with PHB in the PHB/PEG blends produced by solvent cast method [136] . The blends of PHB with PEG400 at various concentrations were shown to enhance the elongation at break approximately up to four times as compared to PHB. The presence of PEG also lowered the melting temperature of PHB in PHB/PEG blends which is due to the plasticizing effect of PEG that reduced the intermolecular forces between the contiguous polymer chains [136] . Blending of [P(3HB)] or [P(4HB)] with PHB significantly improved the elongation at break as well as the mechanical properties of the blends [137] . This study also reported that the addition of an antioxidant 1010 along with PHBHHx or [P(3/4HB)] could increase the thermal stability of PHB. Moreover, a combination of antioxidant 1010, dioctyl sebacate (ATBC) and PHB/PHBHHx or [P(3/4HB)] was suggested to facilitate the processing of PHB. In a nanocomposite composed of PHB, cellulose nano whiskers (CNWs) and PEG, it was found that the CNWs (up to 0.45 wt%) were covered by PEG and the interaction between CNWs and PHB biopolymer took place preferentially with PEG [138] . PEG also exhibits a lubricating effect in the composites prepared with PHB and natural fibers.
Besides these previous studies suggested that many other materials can be used as plasticizers. for example, glycerol, oxypropylated glycerin (or laprol), glycerol triacetate, 4-nonylphenol, acetyl tributyl citrate, acetylsalicylic acid ester, salicylic ester, dioctyl phthalate, dibutyl phthalate, soybean oil, epoxidized soybean oil, acetyl tributyl citrate, di-2-ethylhexylphthalate, triacetine, triethyl citrate, tri(ethylene glycol)-bis(2-ethylhexanoate) and fatty alcohols with or without glycerol fatty esters [139, 140] . 
Nanocomposites of PHA blends
A nano-biocomposite was prepared by blending PHB/V with organo-modified montmorillonite (OMMT) clay as a nanofiller and acetyl tributyl citrate as a plasticizer [141] . These nanobiocomposites exhibited superior mechanical, proper biodegradation kinetic and barrier properties with an intercalated/exfoliated structure of the nanoadditive. The OMMT clay nanofiller facilitated crystallization of the biopolymer by acting as a nucleating agent and the clay nanofiller also improved the thermal stability of the composite by acting as a thermal barrier. Lignin and wood flour derived from different origins served as fillers for the preparation of composite materials and the natural fibers (e.g. wood fibers) acted as load bearing element in the composite materials [147] .
PHB nanocomposites made up of bacterial cellulose nanofibrils showed superior mechanical properties and improved the biocompatibility as they facilitated adhesion of fibroblast cells obtained from Chinese hamster lung [148] . An intercalated nanocomposite of PHBHV-clay was developed by using melt extrusion in a Brabender mixer at 165 °C, and at 50 rpm for 15 min [149] . Zhang et al. [150] described the preparation of PHBHHx/layered silicates and PHBHHx/expanded graphite nanocomposites. where a lower content of nanofiller facilitated the production of an exfoliated morphology with good dispersion. PHA/folate ligand nanocomposite particles were shown to carry doxorubicin for anticancer therapy [151] [152] [153] . Shape memory polymer nanocomposites are of great interest as they are able to revert to their original shape after being deformed. Therefore, these nanocomposites can be used in areas such as biosensors, dry adhesion, microfluidics and tissue engineering. One such shape memory polymer nanocomposite was developed from poly(3-hydroxyoctanoate-co-3-hydroxyundecenoate) with nanofillers of silsesquioxane (POSS) [154] .
Applications in Tissue Engineering and Regenerative Medicine
The core notion of tissue engineering and regenerative medicine is that biomaterials have to mimic many roles of extra cellular matrix (ECM) and structure of the target tissue which are intended to be replaced. Biomaterial is expected to encourage hosts auto repair mechanism with controlled cellular growth. Simultaneously, it should provide mechanical support during the remodeling stage of damaged tissue by leaving wholesomely and nontoxic substance in the biological system.
Orthopedics
PHA research on load-bearing orthopedic applications is a novel approach of tissue engineering for the treatment of lost or damaged hard tissue. Owing to the limited capacity of cartilage self-repair and a vast shortage of donors are the great challenges of articular cartilage repair. These can be partly addressed with suitable composite. An ideal hard tissue biomaterial should initiatively participate and facilitate cell migration, attachment, proliferation and stimulate osteoblast and chondroblastic differentiation and guide the stromal cells until the maturity of chondrocytes. Poor guidance may dedifferentiate stromal cells and lose chondrocytic phenotype which may undergo hypertrophy (a condition where cell dies by a mechanism that is morphologically distinct from apoptosis) or turn to osteoblast. PHA based hard tissue engineering usually focuses on small chain length and medium chain length of PHA because of its crystalline nature, flexibility and degradation profile [13] . Low tensile strengths of PHA-MCL together with other suitable compounds will improve load-bearing ability. In PHA family, poly-3-hydroxybutarate, copolymers of 3-hydroxybutarate and 3-hydrosyvalerate, poly-4-hydroxybutrate, copolymers of 3-hydroxybutarate and 3-hydroxyhexanoate and poly-3-hydroxyoctanoate are suitable candidates for orthopedic applications. [P(3HB)] copolymerization boosts the final product with improved mechanical properties such as good adhesion, enhanced proliferation and better differentiation [5, 155] . PHB showed a reliable bone tissue adaptation and bone was rapidly formed close to the material with minimal or no chronic inflammation response was observed near implant for a year [156] .
You et al. [157] demonstrated PHBHHx coated with PHA binding protein fused with arginylglycyl-aspartic acid (PhaP-RGD) scaffold seeded with human bone marrow mesenchymal stem cells (hBMSCs) produced more ECM, sulphated glycosaminoglycans (sGAG), expressed SOX-9, aggrecan and type II collagen specific genes of chondrocyte. The aforementioned scaffold supported homogeneous spread of cells, improved adhesion, proliferation and chondrogenic differentiation. Green fluorescence of Phap-RGD coated scaffolds was demonstrated more intensive and wider distributed hBMSCs after 72 hours compared with that on 4 hours especially on the PhaP-RGD coated scaffolds. PhaP coated scaffolds showed weaker fluorescence intensity (Fig. 8) . This suggests that the PhaP-RGD coated PHBHHx scaffold is a suitable candidate for chondrogenic differentiation of hBMSCs and can possibly support cartilage tissue engineering [157] . Another study evaluated the control group by using 3D PHBHHx scaffold with engineered -PHBHHx in rabbit for articular cartilage repair [158] . Scaffold was loaded with rabbit chondrocytes and grafted. Subsequently, after 16 weeks of implantation, a successful cartilage repair with full thickness, improved the surface integrity and a better distribution of ECM was obtained as compared to the control [158] . Zheng Z et al. [159] presented that PHBHHx has better mechanical properties compared with PHB. Blends of PHB:PHBHHx of 1:1 ratio possessed the highest surface free energy and is the most optimal material for chondrocytes adhesion and was found to have five times more cell adhesion (2.1 x 10 4 cells/cm 2 ) compared to on the PHB films (0.4 x 10 4 cells/cm 2 after 24 hours) [159] . In a similar study, PHB/PHBHHx of 1:2 ratio scaffold showed a sharp increase of GAG after 7 days of cultivation as compared to PHB alone. PHB/PHBHHx of 1:2 ratio also has shown an almost 4-folds increase in the total collagen content with time as compared to PHB scaffold. This suggests the presence of precise proportion of PHBHHx in the composite system could be highly potential for the production of ECM of articular cartilage chondrocytes [160] . The PHB/BG (poly(3-hydroxybutrate/Bioactive glass -45S5) composite foams were found to be suitable for osteoblast cells (MG-63) attachment and proliferation and even after a week of implant showed no immune response in rats [161] . Due to these favorable properties, PHA materials have been used to produce scaffolds for bone and cartilage repair, spinal cages or internal fixation devices (screws) and as bone graft substitution [13, 162] . Further research is needed to design a scaffold which can channel up chondrogenic differentiation and simultaneously govern the mature chondrocytes without dedifferentiation and hypertrophy. 
Cardiovascular
Heart disease is the major threat of death worldwide and expected to increase in the coming years [163] . It is necessary to understand the underlying mechanism which is responsible for malfunctioning of arteries and veins, to engineer the cardiovascular scaffold with precise demand of cardio system. Enormous strength, flexibility and durability require maintaining the continuous cyclic mechanical loading of blood with every heart contraction. Most of the graft materials (artificial graft, autologous tissue, allograft and xenograft) [164] in the current applications are associated with many demerits such as the risk of thromboembolism (obstruction of a blood vessel by a blood clot that has become dislodged from another site in the circulation), calcification, immune responses, poor stability, prosthetic valve endocarditis and replacement. PHA composite possesses stiffness and elastomeric tendency to endure cyclic stresses and strains exerted upon implantation [165] . A trileaflet heart valve scaffold consisted of a cylindrical stent (1 mm X 15 mm X 20 mm I.D.) containing three valve leaflets was fabricated and modified by salt leaching technique to form pores in the size range from 80 to 200 microns. The resultant scaffold was preloaded with vascular cells (ovine carotid artery). After 4 days of incubation, the scaffold was tested with pulsatile flow bioreactor where the leaflets moments were observed [166] . The native pulmonary leaflets valve was resected and 2 cm segments of pulmonary artery were replaced by autologous pre-seeded scaffold. All the test animals survived during the observation period and were sacrificed at the set time intervals (1, 5, 13 and 17 weeks). Examined constructs were not only covered by tissue and nonthrombus, but also GAG as ECM and collagen were predominantly noted. These results suggest that PHA construct may be used for implants in the pulmonary position with a suitable function [167] . In another study of lamb model, polyglycolic acid-poly-4-hydroxybutyrate (PGA-PHA) preseeded scaffolds were implanted in the abdominal aorta and this implant changed towards those of native blood vessels overtime [96] . Fabricated scaffolds of PGA/[P(4HB)] trileaflet stented heart valves were intact after 4 weeks of culturing. Dynamic and static conditioning resulted in more homogeneous tissues with increased collagen and GAG content compared with control group. The growth and remodeling ability of PGA/[P(4HB)] implant pre-loaded with vascular cells was the first evidence of growth of living cells with the mechanical properties of pulmonary arteries. This scaffold in the presence of basic fibroblast growth factor (bFGF) and ascorbic acid demonstrated better proliferation of human pediatric aortic cells and collagen deposition [168, 169] . Therefore, engineering of suitable PHA composites is considered to be the potential alternatives of cardiovascular biomaterials [5, 170, 171] .
Nerve
Nerves are composed of motor, sensory and sympathetic components where their regeneration is a multifaceted biological phenomenon. In peripheral nervous system (PNS), minor injuries of nerves are regenerated by their own auto repair cascade, but major injuries should undergo nerve autograft. Nerve tissue engineering is followed primarily for the treatment of damaged PNS and neurodegenerative diseases. Auto repair of injured spinal cord impede by few factors but the recent advances in neuroscience, cell culture, molecular protocols and biomaterials at molecular level provide optimism for new treatment. Ideal nerve material should carry multiple tasks for regeneration. In neuroscience, PHA was widely investigated to attain many approaches. Copolymer PHBHHx has shown robust potential by promoting neural stem cell (NSC) differentiation into neurons compared to poly(3-hydroxybutyrate and copolymer of 3-hydroxybutyrate and 4-hydroxybutyrate [172] . The 2D and 3D matrices of PHA were designed via phase separation technique to mimic ECM, whereby in vitro test performed using rat-derived NSCs demonstrated better attachment, growth and differentiation which is suitable for treating CNS injury [172] . The 3D was better over 2D matrices considering NSC attachment and neurite formation [172] . Wang et al. [173] demonstrated that PHB/VHHx 3D scaffold promotes intensive differentiation of (hBMSCs) into nerve cells as compared to 2D films. Additionally, a pore size of 30 to 60 μm was found to enhance the differentiation of hBMSCs into nerve cells. This was confirmed with the expression of nerve markers nestin, GFAP and β-III tubulin, besides the attachment and proliferation [173] .
Yu-Zhu Bian et. al. [92] investigated the suitability of PHBHHx uniform wall porosity and nonuniform porosity nerve conduits in adult Sprague-Dawley (SD) rats. The conduits were employed to bridge the 10 mm defects in the sciatic nerve of SD rats. Both conduits were permeable to glucose, lysosome and bovine serum albumin (BSA) and showed suitability for the free exchanges of nutrients. Nerve conduits have shown good mechanical properties such as maximal stress of 2.3 MPa with uniform wall porosity and 0.94 MPa for non-uniform wall porosity. Similarly, maximal loads of 3.1 N noted for uniform wall porosity and 1.3 N for non-uniform wall porosity. The mechanical property indicated a rapid functional recovery for the disrupted nerves by compound muscle action potentials Preprints (www.preprints.org) | NOT PEER-REVIEWED | Posted: 15 August 2018 doi:10.20944/preprints201808.0271.v1
(CAMPs) after a month of implant in SD rat [92] . Gao et al. [174] observed that PHBHHx holds better crystallinity than PHBHHx/PDLLA. It was found that the highly aligned microarchitecture was capable of mimicking the native nerve tissue and thus assisted better regeneration of injuries across the long nerve gap [174] . Collagen is the most abundant ECM protein in the nerve and exhibited nanofibrous architecture [174] . PHBV and composite PHBV/collagen nanofibers were fabricated with different ratio and their potential for nerve regeneration was evaluated using PC12 nerve cells. PHBV (50) : collagen (50) nanofiber was found to have higher nerve cell proliferation as compared to other ratio and PHBV mat [175] .
Drug delivery
Drug delivery is an interdisciplinary emerging medical field that has been rampantly investigated to enhance competency. Precise sustain drug delivery, suboptimal bioavailability, minimum effect on target site and potential cytotoxicity are the few limitations of current drug delivery system. Therefore. precise targeting and controlled drug delivery of pharmacologically active materials to specific site such as organs, tissues and cells can improve effective drug delivery practices. In recent years, biomaterial engineering has proven in offering better nano-scale carriers (biocompatible and degradable) with effective delivery system of small-molecule drugs, peptides, proteins, plasmid DNA and synthetic oligodeoxynucleotides, besides maintaining minimal side effects. The physiochemical, mechanical and functional tuning properties of PHA's and their origin from natural sources were considered to be fruitful which made PHA as an attractive candidate as a drug delivery vector. Lu et al. [176] demonstrated the potential of PHA nanoparticles as drug carrier (TGX221, an inhibitor of Pl3K) in anticancer study.
PHA microspheres or microcapsules have been extensively used as carriers for sustained release of different drugs such as antibiotics, anesthetics, anticancer agents, anti-inflammatory agents, hormones, steroids and vaccines [177, 178] . PHA microspheres which are smaller in size are distributed mostly in uniform sizes and have high porosity, which are suggested to assist in the loading of a higher amount of drugs. The homopolymers of PHB, PHBV and their copolymers or blends were effective carriers for the controlled release of drugs. However, copolymers possess harmonic porosity that tone down burst release of drug and are therefore more useful for the formulation of sustained drug release systems [179] [180] [181] . Macrophages were shown to intake PHB and PHBHHx nanoparticles (150 -250 nm) efficiently without causing any loss in the cell viability and the polymers were found to provide sustained release of drugs (gentamicin and 5-fluorouracil) for more than 20 days [182, 183] . A high content of PCL in PHBV/PCL blended microparticles with different drugs (indomethacin/diclofenac/dexamethasone) resulted into an increase in the pore size and hence increased the release rate. Furthermore, the release rate of diclofenac and indomethacin from PHBV/PCL microparticles was found to be significantly higher than that of dexamethasone [184, 185] . Extremely hydrophobic PHA are not appropriate for biomedical applications especially for drug delivery systems, hence there is a need to modify them towards hydrophilic nature. Blending of hydrophobic PHB with hydrophilic block copolymer (1:1 ratio) was shown to mitigate the burst release of ibuprofen as compared to PHB or PHB/block copolymer blend (3:1 ratio) [186] .
Recently, PHA was reported as a carrier for anticancer drug delivery system [176] . A sustained release of P13K inhibitor (TGX221) was observed from PHA based nanoparticles and the growth and proliferation of cancer cell lines were significantly halted when treated with PHA-TGX221 nanoparticles. In the treatment of colon cancer through oral drug delivery systems, the drug must be protected from highly acidic gastro-intestinal environment and the drug release has to be under alkaline conditions of colon. To pursue the challenge, Chaturvedi et al. [187] developed pHresponsive microspheres of PHB/ionic cellulose acetate phthalate (CAP) blend to deliver an anticancer drug, 5-fluorouracil ( Fig.9 (1) ). It was shown that the PHB/CAP (1:1) microspheres significantly decreased the release of the drug (only 12%) in 2 h at a pH of 1.2 in comparison to 20% for PHB microspheres. Interestingly, the drug was released up to 72% from the PHB/CAP (1:1) microspheres afterwards in 24 h at a pH of 7.4. SEM images recorded after the dissolution experiments. The microspheres of PHB/CAP (1:1) blend developed fine pores due to the dissolution of CAP in alkaline medium leading to higher release of 5-FU compared to acidic medium. Whereas the PHB microspheres remained intact ( Fig.9(2) ) [187] . In another study, the release of antitumor drug rubomycin from PHB nanoparticles demonstrated an efficient inhibition of Ehrlich's carcinoma proliferative activity in mice [188] . PHB microspheres containing the antitumor drug 2',3'-diacyl-5-fluoro-2'-deoxyuridine showed a modest toxicity and superior compatibility in rats and mice [189] . Cisplatin is a chemotherapeutic agent that is useful against a range of tumors. In a recent study, Shah et al. [190] developed a novel amorphous amphiphilic block copolymer [P(3HV-co-4HB)]-bmPEG nanoparticles loaded with cisplatin to determine the bioavailability and efficacy of cisplatin loaded nanoparticles against tumor. It was shown that the nanoparticles provided a sustained release of drug in vitro. Furthermore, the cisplatin-loaded nanoparticles exhibited an acceleration of apoptotic process of the tumor cells and also suppressed the growth of tumor cells' upon internalization of the nanoparticles [190] . Targeted drug delivery systems are useful for delivering drugs to a specific site of the body where it is needed. These systems can prevent any adverse effects that the drugs may have on other organs or tissues especially in the case of delivering highly toxic drugs such as chemotherapeutic drugs. Recently, rhodamine B isothiocyanate (RBITC) drug was targeted to deliver to macrophages or cancer cells by a receptor mediated drug delivery system [22] . The drug was incorporated into [P(HB-co-HHx)] polymer and was associated with a recombinant PhaP phasin protein from C. necator. These recombinant phasins were fused with human epidermal growth factor (hEGF) (which is recognized by receptors on hepatocellular carcinoma cells) and mannosylated human alpha 1 acid glycoprotein (hAGP) (which is recognized by receptors on macrophages) for targeting cancer cells or macrophages, respectively [22] .
PHA also holds the prospect of being effective in the treatment of highly resistant infections due to its capability for provision and preservation of an adequate amount of antibiotic drugs at the site of infections [191, 192] . Biodegradable and easily implantable rods of PHB, PHBV and [P(3HB-4HB)] polymers loaded with antibiotics were prepared and found to be useful for the local delivery of drugs in chronic osteomyelitis therapy [60, 193, 194] . Tetracycline is an antibiotic which is effective against numerous periodontal disease-related microorganisms. Tetracycline, both in its neutral form (TCN) and in acidic from (TC) was loaded in the PHBV microcapsules and microspheres for developing a sustained release system of antibiotics [58] . This study showed that the antibiotics from PHBV microcapsules and microspheres released gradually and completely before the appearance of any signs of degradation in the polymer. [P(HB-co-HV)] copolymer rods soaked with either sulperazone or gentamicin showed a sustained release of drugs into aqueous solution for a period of 2 weeks. Additionally, the sustained release of sulperazone drug was observed to be extended for more than 60 days when an increased concentration of HV was used in the copolymer (20% HV compared to 7% or 14% HV) [192] . In another study, [P(HB-co-HV)] copolymer discs impregnated with gentamicin were also suggested to provide sustained release of drug, whereby the drug release rate was higher with the higher content of HV in the polymer (12% 3HV vs. 8% HV) [180] . Moreover, the [P(HB-co-HV)]/gentamicin combination produced no adverse effects on the normal human blood samples as no proliferation of white blood cells, red blood cells or platelets was observed [180] . [P(3HB-co-4HB)] was also suggested as an effective copolymer in releasing the drug in solution [60] . Tamulosin was incorporated into poly(hydroxyhexanoate-co-hydroxyoctanoate [P(HHx-co-HO)] polymer and the polymer was found to effectively release the drug to skin [162] . PHA-drug microspheres which are further entrenched into a matrix could produce tissue engineering scaffolds. Nanofiber mats consist of PHBV polymer, drugs (metformin hydrochloride or metoprolol tartrate) and a small amount of surfactants (sorbitan monooleate, Span 80) that can serve as drug encapsulation matrix as well as tissue engineered scaffolds were prepared using an emulsion electrospinning technique [195] . These emulsion electrospun nanofiber mats led to the suppression of initial burst release of drug and achieved a sustained release of drugs as compared to blend electrospun nanofibers [195] .
Wound management
PHA contributes in a variety of wound management products such as surgical sutures, biodegradable membranes, surgical meshes, wound coverings and skin regeneration [74, 196] . Early conventional fibrous mat such as gauze [197, 198] and greasy gauze [199] are being used in clinical practices but have their own limitations like disruption of wound bed, poor integration and scar formation [200] . In recent years, wound management and polymer researchers are continuously looking into suitable bioactive and interactive biomaterials which can involve in wound healing cascade besides bactericidal. Compared to other polymers, PHA is responsive enough to integrate with the choice of blends, functional groups and active compounds, which are all providing adoptable biological, mechanical properties and drug release in the time frames beneath physiological environments. Zonari et al. [201] demonstrated in vitro studies of human skin fibroblastic cells which were well adhered and proliferated on PHBV 2D films and PHBV fibers. Their results showed a significant up-regulation of collagen I and elastin as compared with tissue cultured polystyrene (p > 0.05), which was used as a control. This suggests that PHBV stimulates collagen synthesis and accelerates re-epithelialization to nearly pre-wounded stage [201] . In another study, PHBV scaffold loaded with adipose derived stem cells were found to stimulate the expression of VEGF and bFGF, which not only aids the formation of apt blood vessels, a key factor of wound healing but also regulated TGF-β1, TGF-β3, α-SMA for scar management [93] .
PHA films electrospun with different copolymer ratio and concentration were subcutaneously implanted into rat for up to 12 weeks. Histological results demonstrated that [P(3HB-co-97 mol%4HB)] was extensively degraded because of its low content of 3HB, whereas [P(3HB)], [P(3HB-co-5mol%-3HH)] and [P(3HB-co-7mol%-4HB)] contained a higher content of [P(3HB)] which are more crystalline and hence a slower rate of bioabsorption was observed [202] . However, macrophages from wound site expressed messenger RNA transcripts for PDGF (platelet-derived growth factor A-chain), insulin like growth factor-1 and TGF-alpha, which may facilitate important factors of wound healing such as angiogenesis, epidermal regrowth and the formation of granulation tissue [203] . Also to be noted are the tensile strength (5-30 MPa) and Youngs modulus (15-150 MPa), which were comparable to those of human skin [19] , suggesting PHA as mechanically suitable.
A blend of [P(3HB)]/[P(3HB-co-3HHx)] and [P(3HB)]/[P(3HB-co-4HB)] matrices prepared by phase separation resulted in interconnected fibers with diameter ranging from 50 to 500 nm, which is similar to a 3D structure. Average diameters of fibers are similar to collagen (major component of ECM) which plays a key role in stimulating the cellular response. Human keratinocyte cell line, HaCat were seeded onto nanofibrous matrices which showed better morphology, adhesion and viability as compared to solvent casted film of the same blend [204] . PHA based micro-particles incorporated with anti-inflammatory agents accelerated wound healing in comparison with routine therapies and were found to be useful in long-acting drug which could minimize frequent confiscate of neo-wound bed [205] . In the near future, a frequent change of wound scaffold could be minimized to zero by incorporating a sensing system. Chen et al. [206] developed a smart bandage which monitors and inhibited wound infection. In vitro and in vivo studies proved it a dual luminescent system. Fluorescent color changes of the smart bandage from red to blue occurred upon the stimulation of reactive oxygen species at an elevated pH (Fig. 10) . Similarly, fluorescent dyes can be employed to indicate the percentage of available drug in the scaffold by changing the color of scaffold from green (100%) to yellow, orange to red (no drug) or by luminescence. Best to our knowledge so far there has been no reports on the percentage of drug indication alarm. This saves the wastage of drug, wound bed confiscation and valuable time of health professionals. PHA can be an interesting candidate for the ongoing revolt in wound management. The total sensing and drug delivery scheme are made on a flexible polymeric substrate called smart bandages or flexible bioelectronics [207] . This provides insights into the true scenario of wound healing cascade which is in-progress under the smart scaffold. Furthermore, smart bandages are optimized with the parameters such as pH, oxygen, moisture, temperature, pressure and also sense infection as well as auto-release in which the required amount of drug is released when needed [208, 209] . Petar et al. [210] (Fig. 11) constructed a smart bandage with biosensors for the determination of uric acid (UA), an important biomarker of wound. Biosensor interfaces with potentiostat which communicates on demand wireless data transmission of UA to connected devices such as computer, tablet or smartphone through near-field communication or radio frequency identification. Smart bandage pleasantly updates the healing status to health professionals tagged with the smart bandage governing system. Looking into the developments the future scaffolds are expected to have great potential to improve healthcare immensely. 
Conclusion
Although PHA has been extensively used for variety of applications and research, particularly in medicine, it has a limited potential due to its low functionalities, high production cost, and complicated purification methodologies. To address these challenges, it is necessary to identify and develop a high PHA producing strain with advance fermentation technology for obtaining mass production at lower cost. Further insight into, prevention of early PHA biosynthesis at log phase (mitosis) may increase the cell density which might result in higher production of PHA. Moreover, metabolic engineering may be another efficient tool to obtain the precise structures of PHA with unique monomers and the biogenic extraction using suitable macro hosts.
On the other hand, PHA modification through physical blending and chemical alteration will allow the resulting PHA with high value added properties. Here in this review we briefed the modification of PHA functionality through blending of various natural, synthetic raw materials and nano materials. Blending is an easy and effective method where many biodegradable polymers, growth factors, and drugs are mixed together and processed. Starch, a biocompatible polymer, blended with PHA, has shown an improved biocompatibility of starch/PHA blend scaffold. Blending of PHA with other compatible materials reduces the effective cost of biomedical based products as compared to pure PHA copolymer such as [P(4HB)]. Significantly modified PHA blends have shown improved thermal stability, sustain biodegradation, tensile strength, flexibility, enhanced load bearing efficacy, wettability, superior mechanical, rheological and various physicochemical properties. The modified properties from PHA blends would enhance the strength of its use in diverse biomedical applications such as orthopedic, cardiovascular, drug delivery and wound management. Due to the versatility structures of PHA which can be simply modified, it is an emerging candidate to further investigate and blend with a wide variety of nanoparticles, nanocomposites and other polymers to have properties those are more suitable for medical application and different tissue engineering fields. Scaffolds developed from PHA like 3D structures, microspheres or microcapsules etc. offer unique techniques of controlled, sustain drug delivery, cell attachment and proliferation. Therefore, one can envision the release of hormones, immunomodulators and cell guide (example; chondrocyte untill the maturity) using PHA system. Many other PHA based products are feasible that may perhaps perform wide verity of functions by auto switchable surface in the bio environment. Procedures for fabrication of PHA based scaffolds could involve the expertise from biopolymer scientists, tissue engineers, microelectronic scientist, and medical doctors. In near future, PHA base bio-smart products maybe use for a range of applications that possibly will do much more than just a drug delivery.
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